EFFICACY OF INDUCTION UPADACITINIB THERAPY IN EAST ASIAN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Minhu Chen  ¹     Gao Xiang  ²     Kenji Watanabe  ³     Toshimitsu Fujii  ⁴     Jae Hee Cheon  ⁵     Shu Chen Wei  ⁶     Dennis Teng  ⁷     Ana Paula Machado De Lacerda     Valencia Remple     Hiroshi Nakase  ^8    
1 The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
² The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
³ Hyogo Medical University, Nishinomiya, Japan
⁴ Tokyo Medical and Dental University, Tokyo, Japan
⁵ Yonsei University, Seoul, Korea, Republic of
⁶ National Taiwan University Hospital, Taipei, Taiwan, Province of China
⁷ AbbVie Inc., North Chicago, United States
⁸ Sapporo Medical University, Sapporo, Japan

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)